Skip to search formSkip to main contentSkip to account menu

HNS 32

Known as: HNS-32 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Active faceted Cu2O hollow nanospheres for unprecedented adsorption and visible-light degradation of pollutants.
2018
2018
Open Access: Is There a Predator at the Door?
Neurogenic inflammation plays a role in the pathophysiology of allergic rhinitis. Highly effective in reducing the sensory… 
Review
2018
Review
2018
Challenges faced by young otolaryngologists-head & neck surgeons around the world.
Review
2017
Review
2017
Securing an OTL-HNS residency: how competitive is it? Comparing medical student perceptions to actual Canadian statistics
BackgroundThe residency match is an important event in an aspiring physician’s career. Otolaryngology – Head and Neck Surgery… 
2017
2017
Evolution of gender representation among Canadian OTL-HNS residents: a 27-year analysis
BackgroundThe proportion of females enrolling into medical schools has been growing steadily. However, the representation of… 
2017
2017
Plasmon enhanced light absorption in aluminium@Hematite core shell hybrid nanocylinders: the critical role of length
The light absorption as well as the near field enhancements properties of Al@α-Fe2O3 core shell hybrid nanocylinders (HNs) have… 
2002
2002
Cardiovascular effects of orally administered HNS-32, an originally synthesized azulene-1-carboxamidine derivative, assessed in the in vivo rat model.
HNS-32, an azulene-1-carboxamidine derivative, is an originally synthesized antiarrhythmic compound. Its cardiovascular effects… 
Review
2001
Review
2001
A review of HNS-32: a novel azulene-1-carboxamidine derivative with multiple cardiovascular protective actions.
HNS-32 [N(1),N(1)-dimethyl-N(2)-(2-pyridylmethyl)-5-isopropyl-3,8-dimethylazulene-1- carboxamidine] (CAS Registry Number: 186086… 
2001
2001
Effects of HNS-32, a Novel Antiarrhythmic Agent, on Guinea-Pig Myocardium
The electrophysiological and mechanical effects of HNS-32, a novel azulene-1-carboxamidine derivative with antiarrhythmic… 
2000
2000
HNS-32, a novel azulene-1-carboxamidine derivative, inhibits nifedipine-sensitive and -insensitive contraction of the isolated rabbit aorta
Abstract. The vasorelaxant profile of a novel azulene-1-carboxamidine derivative, HNS-32 [N1,N1-dimethyl-N2-(2-pyridylmethyl)-5… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License